As shown in Fig. 5E, the birinapant treatment significantly promoted the migration of IL2- and anti-CD3-activated Jurkat T cells from the upper chamber to the cancer cell culture in the bottom chamber (Fig. 5F, G and Supplementary Fig. S10C). Here, IL2 is linked to cancer.